These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3038666)

  • 1. Age-related changes in brain biogenic monoamines and monoamine oxidase.
    Petkov VD; Stancheva SL; Petkov VV; Alova LG
    Gen Pharmacol; 1987; 18(4):397-401. PubMed ID: 3038666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in brain neurotransmission.
    Petkov VD; Petkov VV; Stancheva SL
    Gerontology; 1988; 34(1-2):14-21. PubMed ID: 2898418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat brain monoamine metabolism and hypobaric hypoxia: a new approach.
    Trouvin JH; Prioux-Guyonneau M; Cohen Y; Jacquot C
    Gen Pharmacol; 1986; 17(1):69-73. PubMed ID: 3949151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats).
    Petkov VD; Stancheva SL; Tocuschieva L; Petkov VV
    Gen Pharmacol; 1990; 21(1):71-5. PubMed ID: 2105261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the nootropic agents adafenoxate and meclofenoxate on brain biogenic monoamines in aged rats.
    Stancheva SL; Petkov VD; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(1):14-21. PubMed ID: 3136616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the brain biogenic monoamines of rats, induced by piracetam and aniracetam.
    Petkov VD; Grahovska T; Petkov VV; Konstantinova E; Stancheva S
    Acta Physiol Pharmacol Bulg; 1984; 10(4):6-15. PubMed ID: 6535371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic diazepam and medazepam treatment on the level of biogenic monoamines in different rat brain areas.
    Stancheva S; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(3):26-31. PubMed ID: 2906206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variations in the monoamine levels and monoamine oxidase activity in different regions of the rat brain as a function of age.
    Bhaskaran D; Radha E
    Exp Gerontol; 1984; 19(3):153-70. PubMed ID: 6479252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VD; Konstantinova E
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats].
    Miroshnichenko II; Kudrin VS; Raevskiĭ KS
    Farmakol Toksikol; 1988; 51(2):26-9. PubMed ID: 2897932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of brain monoamines in lean and obese female Zucker rats.
    Orosco M; Trouvin JH; Cohen Y; Jacquot C
    Physiol Behav; 1986; 36(5):853-6. PubMed ID: 2424037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat.
    Kueng W; Wirz-Justice A; Menzi R; Chappuis-Arndt E
    Neuroendocrinology; 1976; 21(4):289-96. PubMed ID: 1035790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain.
    Stancheva S; Grahovska T; Petkov VV
    Acta Physiol Pharmacol Bulg; 1985; 11(1):3-9. PubMed ID: 4036650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late changes in cerebral monoamine metabolism following focal ventrolateral cerebrocortical lesions in rats.
    Finklestein S; Campbell A; Baldessarini RJ; Moya KL; Haber SN
    Brain Res; 1985 Oct; 344(2):205-10. PubMed ID: 2412650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of monoamines in the recovery of the conditioned reflex activity of rats following extirpation of the frontal cortex].
    Grekhova TV; Kudrin VS; Miroshnichenko II; Romanova GA
    Biull Eksp Biol Med; 1987 Jan; 103(1):12-4. PubMed ID: 3801640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging.
    Míguez JM; Aldegunde M; Paz-Valiñas L; Recio J; Sánchez-Barceló E
    J Neural Transm (Vienna); 1999; 106(11-12):1089-98. PubMed ID: 10651105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neonatal nociceptin or nocistatin imprinting on the brain concentration of biogenic amines and their metabolites.
    Tekes K; Gyenge M; Sótonyi P; Csaba G
    Brain Dev; 2009 Apr; 31(4):282-7. PubMed ID: 18597961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical resistance to development of morphine-dependence in rats: biogenic amines, its receptors and antibodies.
    Rusakov DJ; Borisova EV; Tronnikov SI; Kuznetzova MN; Veretinskaya AG; Gamaleya NB; Sudakov SK
    Drug Alcohol Depend; 1992 Aug; 30(3):289-92. PubMed ID: 1396110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.